curasan AG: Novel bone regeneration material approved for sale in Europe

30-Mar-2011 - Germany

curasan AG has received European approval for a novel synthetic bone regeneration material. Osseolive® is a bioactive, poly-crystalline calcium-alkali-phosphate ceramic, which has a stimulating effect on bone formation as well as on bone mineralisation.

“With Osseolive® emerging from our well-stocked development pipeline, we now have an ideal extension to our tricalcium-phosphate products”, stated Hans Dieter Rössler, CEO. Osseolive® has been specifically designed for the treatment of large defects in combination with bone growth supporting substances, such as bone marrow aspirate, stem cells, and bone morphogenetic proteins (BMPs).”

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances